Sanguisorba officinalis L. and Sophora japonica L. Inhibit Angiogenesis in Ulcerative Colitis
Journal of Gastroenterology and Hepatology · 2025-08 · 40 (8) · 1991-2006
DOI: 10.1111/jgh.17034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 15.06.2025. Verfasst von Wei Yuzhuo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Sophora, Sanguisorba, Neovascularization, Pathologic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Special Projects for Academic Enhancement of Department Heads, National Natural Science Foundation of China, Suzhou Science and Technology Project.
Abstract (Originalsprache)
Background and Aim Sanguisorba officinalis L. and Sophora japonica L. (SOSJ) have been frequently used as medicinal pairs for treating ulcerative colitis (UC) due to their hemostatic properties. However, the mechanisms underlying their therapeutic effects remain unclear. This study aims to predict the targets of SOSJ for UC treatment using liquid chromatography‐quadrupole time‐of‐flight tandem mass spectrometry (LC‐QTOF‐MS) and network pharmacology.
Methods
The efficacy of SOSJ was evaluated using a 3% dextrose sodium sulfate (DSS)‐induced UC mice model. The general condition of the mice, histopathology, and expression of colonic inflammatory factors were assessed. Additionally, the effect of SOSJ on angiogenesis was evaluated by detecting the mRNA of colonic angiogenesis‐related mediators, measuring microvessel density, and using transmission electron microscopy.
Results
SOSJ significantly attenuated inflammation and inhibited pathological angiogenesis in UC mice. It alleviated weight loss, colon shortening, and the presence of pus and blood in stools. SOSJ also reduced the mRNA expression levels of IL‐6, IL‐1β, TNF‐α, VEGF, VCAM1, Ang1, MMP1, MMP2, and MMP9. Furthermore, SOSJ decreased the protein expression of the PI3K‐Akt pathway, an effect that could be reversed by 740Y‐P, a specific PI3K activator.
Conclusion
S. officinalis L. and S. japonica L. exert therapeutic effects on mice with ulcerative colitis, potentially through the modulation of angiogenesis and the PI3K‐Akt signalling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
- Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, China.
ORCID-Profile: Miao Zhiwei, Xu Yi
Förderung
- Special Projects for Academic Enhancement of Department Heads
- National Natural Science Foundation of China
- Suzhou Science and Technology Project
- Project of National Clinical Research Base of Traditional Chinese Medicine in Jiangsu Province, China
- Jiangsu Province Traditional Chinese Medicine Science and Technology Development Plan Project
- Development Plan for Traditional Chinese Medicine in Jiangsu Province
- CACMS innovation Fund
- Gusu Health Professionals Research Program
Zitieren
APA
Yuzhuo, W., Li, L., Shu, B., Jing, Y., Yongqi, W., Zhiwei, M., & Yi, X. (2025). Sanguisorba officinalis L. and Sophora japonica L. Inhibit Angiogenesis in Ulcerative Colitis. Journal of Gastroenterology and Hepatology, 40(8), 1991-2006. https://doi.org/10.1111/jgh.17034
Vancouver
Yuzhuo W, Li L, Shu B, Jing Y, Yongqi W, Zhiwei M, et al. Sanguisorba officinalis L. and Sophora japonica L. Inhibit Angiogenesis in Ulcerative Colitis. Journal of Gastroenterology and Hepatology. 2025;40(8):1991-2006. doi:10.1111/jgh.17034
BibTeX
@article{Yuzhuo2025,
author = {Yuzhuo, Wei and Li, Liu and Shu, Bu and Jing, Yan and Yongqi, Wang and Zhiwei, Miao and Yi, Xu},
title = {Sanguisorba officinalis L. and Sophora japonica L. Inhibit Angiogenesis in Ulcerative Colitis},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
volume = {40},
number = {8},
pages = {1991--2006},
doi = {10.1111/jgh.17034}
}
EUVIMED